Data / Form D filings / Lennham Pharmaceuticals, Inc.
Lennham Pharmaceuticals, Inc.: Form D filings
Lennham Pharmaceuticals, Inc., a pharmaceuticals company in Concord, MA, filed 2 Form D notices with the SEC between 2021 and 2023. The latest, on April 4, 2023, reports $1.2 million sold of a $1.2 million offering to 13 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 53 MAIN STREET, SUITE 206, Concord, MA, 01742
- Phone
- (617) 388-7171
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2019
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1853301
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 4, 2023 | New notice | $1,200,000 | $1,200,000 | 13 | Oct 28, 2021 | sec.gov | |
| Mar 25, 2021 | New notice | $2,325,000 | $2,325,000 | 19 | Oct 19, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Benjamin D. Enerson | Executive Officer | |
| Bradford C. Sippy | Executive Officer, Director | |
| Corey D. MacGregor | Executive Officer |
Other pharmaceuticals companies in Massachusetts that filed recently
- Land Therapeutics Inc. $17.5 million · Oct 21, 2026
- Crosslink Therapeutics Inc. $5.5 million · Oct 20, 2026
- Sentonix, Inc. $12.7 million · Aug 20, 2026
Every Form D from the week of Apr 3, 2023 · All recent filings in Massachusetts · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Lennham Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.